PHA
Philipp Hess Associates (PHA) is an independent consulting organization founded in 1994, providing project and consulting services to the global biopharmaceutical manufacturing sector. Their mission is to partner with clients in planning, developing, evaluating, and implementing effective manufacturing strategies. Their vision is to create economic bioprocessing networks that sustain performance beyond technological and biotech business changes. PHA leverages decades of implementation experience in biotech manufacturing, from concept and detailed design to stable GMP operations. They are a global, diverse, and reliable organization committed to advancing biotechnology manufacturing.
Industries
Nr. of Employees
small (1-50)
Services
Consulting engagements to develop manufacturing strategies covering capacity, technology choice and network planning.
Owner’s representative services for major facility projects including project oversight and coordination with engineering teams.
Single-point integrated planning service covering conceptual through detailed design and equipment procurement support.
Feasibility assessments, make-or-buy analyses and investment planning including cost simulations for different production scenarios.
Selection and technical assessment of contract manufacturers, including auditing and capability matching to client requirements.
Operational interventions and methodologies to improve global supply systems and resolve urgent supply chain issues for biologics.
Consulting engagements to develop manufacturing strategies covering capacity, technology choice and network planning.
Owner’s representative services for major facility projects including project oversight and coordination with engineering teams.
Single-point integrated planning service covering conceptual through detailed design and equipment procurement support.
Feasibility assessments, make-or-buy analyses and investment planning including cost simulations for different production scenarios.
Selection and technical assessment of contract manufacturers, including auditing and capability matching to client requirements.
Operational interventions and methodologies to improve global supply systems and resolve urgent supply chain issues for biologics.
Expertise Areas
- Biopharmaceutical manufacturing strategy
- Single-use bioprocessing implementation
- Facility conceptual and detailed design
- Continuous bioprocessing and perfusion
Key Technologies
- Single-use bioprocess systems
- Continuous/perfusion bioprocessing
- Stainless-steel bioreactor systems
- Online capture and continuous chromatography
News & Updates
Vibalogics now Part of Recipharm
General Planner delivering integrated design services from concept to operations to expand flexible Virotherapy GMP Site.
Confidential COVID-19
Feasibility study and fast track implementation preparation for COVID-19 vaccine manufacturing capacity upgrading.
Molecular Templates, USA
Feasibility study, including conceptual design and make or buy assessment for microbial single-use launch and market supply facility for engineered toxin bodies (ETB’s).
apceth Biopharma, D
Conceptual design for expansion of contract manufacturing for cellular therapy facility (MCS’s).
Canton Biologics, PRC
Conceptual design for contract manufacturing facility for recombinant proteins based on cell culture.
MabVenture, PRC
Feasibility study including cost modelling for contract multi-purpose clinical/market supply manufacturing facility based on hybrid stainless steel and single-use technology. Advisor to the project steering group.
Vibalogics now Part of Recipharm
General Planner delivering integrated design services from concept to operations to expand flexible Virotherapy GMP Site.
Confidential COVID-19
Feasibility study and fast track implementation preparation for COVID-19 vaccine manufacturing capacity upgrading.
Molecular Templates, USA
Feasibility study, including conceptual design and make or buy assessment for microbial single-use launch and market supply facility for engineered toxin bodies (ETB’s).
apceth Biopharma, D
Conceptual design for expansion of contract manufacturing for cellular therapy facility (MCS’s).
Canton Biologics, PRC
Conceptual design for contract manufacturing facility for recombinant proteins based on cell culture.
MabVenture, PRC
Feasibility study including cost modelling for contract multi-purpose clinical/market supply manufacturing facility based on hybrid stainless steel and single-use technology. Advisor to the project steering group.